Spotify
Google Podcasts
Apple Podcasts
Breaker
Overcast
Pocket Casts
Radio Public
Anchor
Esperion Therapeutics Stock Price (Quote) NASDAQ:ESPR
$3.77 ( 1.07% ) Thursday, 20th Jan 2022
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $3.61 | $5.41 | Thursday, 20th Jan 2022 ESPR stock ended at $3.77. This is 1.07% more than the trading day before Wednesday, 19th Jan 2022. During the day the stock fluctuated 6.43% from a day low at $3.73 to a day high of $3.97. |
| 90 days | $3.61 | $10.83 | |
| 52 weeks | $3.61 | $39.50 |
Historical Esperion Therapeutics prices
| Date | Open | High | Low | Close | Volume |
| 2022-01-20 | $3.76 | $3.97 | $3.73 | $3.77 | 926 126 |
| 2022-01-19 | $3.72 | $3.81 | $3.61 | $3.73 | 995 203 |
| 2022-01-18 | $3.87 | $3.94 | $3.72 | $3.73 | 1 104 986 |
| 2022-01-14 | $3.95 | $4.02 | $3.71 | $3.93 | 1 463 507 |
| 2022-01-13 | $3.98 | $4.14 | $3.87 | $4.13 | 1 087 606 |
| 2022-01-12 | $4.21 | $4.23 | $3.96 | $3.99 | 1 097 680 |
| 2022-01-11 | $4.08 | $4.42 | $4.01 | $4.18 | 1 674 363 |
| 2022-01-10 | $4.20 | $4.20 | $3.90 | $4.03 | 1 387 495 |
| 2022-01-07 | $4.36 | $4.44 | $4.13 | $4.15 | 1 414 520 |
| 2022-01-06 | $4.81 | $4.89 | $4.32 | $4.37 | 2 147 000 |
| 2022-01-05 | $4.95 | $5.05 | $4.71 | $4.76 | 1 289 961 |
| 2022-01-04 | $5.16 | $5.28 | $4.91 | $4.97 | 970 342 |
| 2022-01-03 | $5.05 | $5.25 | $4.84 | $5.19 | 1 140 141 |
| 2021-12-31 | $4.97 | $5.06 | $4.92 | $5.00 | 819 898 |
| 2021-12-30 | $4.79 | $5.14 | $4.79 | $4.96 | 1 796 067 |
| 2021-12-29 | $4.90 | $4.97 | $4.70 | $4.81 | 1 550 554 |
| 2021-12-28 | $5.06 | $5.38 | $4.85 | $4.92 | 1 958 369 |
| 2021-12-27 | $5.38 | $5.38 | $5.00 | $5.07 | 1 658 254 |
| 2021-12-23 | $5.15 | $5.41 | $5.09 | $5.38 | 1 785 790 |
| 2021-12-22 | $5.08 | $5.15 | $5.00 | $5.15 | 1 261 177 |
| 2021-12-21 | $5.20 | $5.29 | $5.05 | $5.13 | 1 096 489 |
| 2021-12-20 | $5.05 | $5.19 | $4.99 | $5.16 | 1 256 907 |
| 2021-12-17 | $5.18 | $5.37 | $5.12 | $5.19 | 2 636 410 |
| 2021-12-16 | $5.34 | $5.44 | $5.09 | $5.15 | 1 345 463 |
| 2021-12-15 | $5.00 | $5.35 | $4.85 | $5.35 | 2 746 252 |
| 2021-12-14 | $5.02 | $5.28 | $4.92 | $5.02 | 1 873 987 |
| 2021-12-13 | $5.17 | $5.43 | $4.88 | $5.06 | 2 388 328 |
| 2021-12-10 | $5.31 | $5.45 | $5.09 | $5.17 | 1 872 260 |
| 2021-12-09 | $5.74 | $5.74 | $5.28 | $5.30 | 4 319 775 |
| 2021-12-08 | $5.62 | $5.91 | $5.52 | $5.87 | 3 186 829 |
| 2021-12-07 | $5.72 | $5.72 | $5.39 | $5.56 | 4 451 616 |
| 2021-12-06 | $5.19 | $5.65 | $5.13 | $5.61 | 6 068 406 |
| 2021-12-03 | $6.09 | $6.10 | $4.96 | $5.25 | 28 744 966 |
| 2021-12-02 | $7.87 | $9.13 | $7.87 | $8.97 | 2 114 547 |
| 2021-12-01 | $8.75 | $9.07 | $8.04 | $8.04 | 2 517 589 |
| 2021-11-30 | $8.47 | $9.05 | $8.10 | $8.73 | 2 585 234 |
| 2021-11-29 | $7.90 | $8.76 | $7.59 | $8.68 | 1 129 743 |
| 2021-11-26 | $7.70 | $7.83 | $7.21 | $7.78 | 1 289 087 |
| 2021-11-24 | $8.49 | $8.68 | $7.50 | $7.69 | 6 977 790 |
| 2021-11-23 | $7.16 | $10.02 | $7.02 | $10.02 | 4 894 800 |
| 2021-11-22 | $7.48 | $7.52 | $6.97 | $7.12 | 898 231 |
| 2021-11-19 | $7.53 | $7.94 | $7.32 | $7.41 | 1 158 387 |
| 2021-11-18 | $7.82 | $7.85 | $7.23 | $7.66 | 980 086 |
| 2021-11-17 | $8.55 | $8.55 | $7.84 | $7.87 | 895 021 |
| 2021-11-16 | $8.59 | $8.66 | $8.34 | $8.51 | 541 811 |
| 2021-11-15 | $8.87 | $8.98 | $8.57 | $8.72 | 839 361 |
| 2021-11-12 | $9.20 | $9.31 | $8.77 | $8.79 | 1 324 552 |
| 2021-11-11 | $9.44 | $9.57 | $9.22 | $9.26 | 927 430 |
| 2021-11-10 | $9.74 | $9.91 | $9.50 | $9.55 | 476 439 |
| 2021-11-09 | $9.90 | $10.20 | $9.71 | $9.84 | 1 106 159 |
Esperion Therapeutics, Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of oral and low-density lipoprotein cholesterol (LDL-C) lowering therapies for the treatment of patients with elevated LDL-C. Its lead product candidate is ETC-1002 or Bempedoic acid, an inhibitor of ATP Citrate Lyase, an enzyme on the cholesterol biosynthesis pathway that is in Phase III long-term safety and tolerability study to... Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
Join 100 000+ Happy Subscribers
Don't miss out on the runners!
![StockInvest.us]()
Stock Podcast
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
